Skip to main navigation
AASLD Family of Websites:
The Liver Meeting
AASLD.org
AASLD Foundation
LiverLearning
Careers
Journals
Liver Fellow Network
HCV Guidelines
Menu
TLM Main Navigation
Claim CE Credits
For Industry
Why Exhibit
Reserve a Booth
Exhibitor Resources
Attend
Register Now
AASLD Foundation
AASLD Members
Exhibit Hall
First Time Attendee
Mobile App & TLMdX
Networking Events
Venue & Housing
Your Safety
Program
Abstract & Program Guides
CE Credits
Global Programming
Satellite Symposia
Schedule
Speakers
TLM Theaters
Register Now
Hyman J. Zimmerman Hepatotoxicity State of the Art: Systemic Therapy for Hepatocellular Carcinoma in 2025—Where Are We Now?
Nov
09
2025
Convention Center: Hall A (General Session), Concourse Level
11:00 AM - 11:30 AM
Live Streamed
Captured
World Class Speakers
Presenter
Laura M Kulik, MD
Northwestern Medical Faculty Foundation
Moderator
Tamar H Taddei, MD, MD, FAASLD
Yale University
Description
Laura Kulik, MD
will present the Hyman J. Zimmerman Hepatotoxicity State of the Art Lecture, "Systemic Therapy for Hepatocellular Carcinoma in 2025: Where Are We Now?"
Journey Maps
Liver Cancer
Presentations
7:26 PM - 7:26 PM
Nov
09
2025
Washington, D.C.
Introduction
Tamar H Taddei, MD, MD, FAASLD, Moderator
Liver Cancer
7:26 PM - 7:26 PM
Nov
09
2025
Washington, D.C.
Systemic Therapy for Hepatocellular Carcinoma in 2025: Where Are We Now?
Laura M Kulik, MD, Presenter
Liver Cancer
Objectives
Discuss the latest developments in the use of systemic therapy to treat hepatocellular carcinoma.